Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2

Pancreatic T reg cells control the availability of CD4+ T cell–secreted IL-2 to limit NK cell function.

• Publication year

  2013

• Venue

  Journal of Experimental Medicine

• Publication date

  2013-06-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/jem.20122248PMID 23650440PMCID 3674700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells

  2013influential reference
• IL-2–dependent adaptive control of NK cell homeostasis

  2013cited by this paper
• Application of IL-2 therapy to target T regulatory cell function.

  2012influential reference
• Exploiting a natural conformational switch to engineer an Interleukin-2 superkine

  2012cited by this paper
• Cutting Edge: A Novel Mechanism Bridging Innate and Adaptive Immunity: IL-12 Induction of CD25 To Form High-Affinity IL-2 Receptors on NK Cells

  2012cited by this paper
• Anti-CD25 Immunotherapy: Regulating the Regulators

  2012cited by this paper
• Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

  2012cited by this paper
• Regulatory T cells: mechanisms of differentiation and function.

  2012cited by this paper
• Immunotherapy in Type 1 Diabetes: A Shorter but More Winding Road?

  2012cited by this paper
• Regulatory T Cells

  2011cited by this paper
• Regulatory T cells and Foxp3

  2011influential reference
• Central Role for Interleukin-2 in Type 1 Diabetes

  2011influential reference
• IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

  2010cited by this paper
• Genomic definition of multiple ex vivo regulatory T cell subphenotypes

  2010cited by this paper
• IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor α subunit CD25

  2010cited by this paper
• Cytokine-induced memory-like natural killer cells

  2009cited by this paper
• Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding.

  2009cited by this paper
• How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.

  2009cited by this paper
• IL-2/Anti-IL-2 Antibody Complex Enhances Vaccine-Mediated Antigen-Specific CD8+ T Cell Responses and Increases the Ratio of Effector/Memory CD8+ T Cells to Regulatory T Cells1

  2008cited by this paper
• T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects

  2008influential reference
• Regulating Treg cells at sites of inflammation.

  2008cited by this paper
• Mechanisms of regulatory T‐cell suppression – a diverse arsenal for a moving target

  2008cited by this paper
• How regulatory T cells work

  2008cited by this paper
• Response: Regulating Treg Cells at Sites of Inflammation

  2008influential reference
• Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

  2008influential reference
• Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.

  2008cited by this paper
• Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.

  2008cited by this paper
• Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

  2007cited by this paper
• Recovery from diabetes in mice by beta cell regeneration.

  2007cited by this paper
• CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells

  2007cited by this paper
• Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways

  2007cited by this paper
• Altered Natural Killer Cells in Type 1 Diabetic Patients

  2007cited by this paper
• Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

  2007cited by this paper
• Recovery from diabetes in mice by β cell regeneration

  2007cited by this paper
• STAT5-Mediated Signals Sustain a TCR-Initiated Gene Expression Program toward Differentiation of CD8 T Cell Effectors1

  2006cited by this paper
• Regulatory T cells

  2006cited by this paper
• Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes

  2006influential reference
• CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer1

  2006cited by this paper
• The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

  2006cited by this paper
• Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.

  2005cited by this paper
• A comprehensive review of interventions in the NOD mouse and implications for translation.

  2005cited by this paper
• CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production.

  2005influential reference
• Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL‐)two to tango

  2005influential reference
• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

  2005influential reference
• Killer Cell Immunoglobulin‐like Receptor Genes in Latvian Patients with Type 1 Diabetes Mellitus and Healthy Controls

  2004cited by this paper
• SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo

  2004cited by this paper
• Elevated TGF-b1 Secretion and Downmodulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

  2004cited by this paper
• Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients1

  2004cited by this paper
• RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo

  2004cited by this paper
• A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation

  2004cited by this paper
• KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.

  2003cited by this paper
• CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

  2003cited by this paper
• Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains.

  2001cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Genetic control of diabetes progression.

  1997cited by this paper
• Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

  1996cited by this paper
• Following a diabetogenic T cell from genesis through pathogenesis.

  1993cited by this paper
• The fate of interleukin-2 after in vivo administration.

  1983cited by this paper
• [Combination treatment].

  1969cited by this paper

• The meninges host a distinct compartment of regulatory T cells that preserves brain homeostasis.

  2025influential citation
• Tongue cancer in pregnancy: challenges and outcomes. A case series and review of the literature

  2025cites this paper
• Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy

  2025cites this paper
• Natural killer cells: the immune frontline against circulating tumor cells

  2025cites this paper
• Protein engineering to overcome limitations of key cytokines in cancer immunotherapy: current approaches and future perspectives

  2025cites this paper
• Intra-Tumoral Treg Ablation Unleashes NK Cell-Mediated Control of CD8 T Cell-Resistant Tumors

  2025cites this paper
• Identification of Immune Gene Signature Associated with T Cells and Natural Killer Cells in Type 1 Diabetes

  2024cites this paper
• Leveraging chemotherapy-induced PD-L1 upregulation to potentiate targeted PD-L1 degradation using nanoparticle-based targeting chimeras

  2024cites this paper
• Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy

  2024cites this paper
• Rebalancing the Immune System to Treat Type 1 Diabetes.

  2024cites this paper
• CD137-expressing Regulatory T Cells in Cancer and Autoimmune Diseases.

  2024cites this paper
• Clinical and basic science aspects of innate lymphoid cells as novel immunotherapeutic targets in cancer treatment.

  2024cites this paper
• Regulatory T cells shield muscle mitochondria from interferon-γ–mediated damage to promote the beneficial effects of exercise

  2023cites this paper
• Expanded ILC2s in human infant intestines promote tissue-growth.

  2023cites this paper
• CD56bright natural killer cells preferentially kill proliferating CD4+ T cells

  2023cites this paper
• CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression

  2023cites this paper
• Killer instincts: natural killer cells as multifactorial cancer immunotherapy

  2023cites this paper
• Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases

  2023cites this paper
• Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy

  2022cites this paper
• Pregnancy and Tumour: The Parallels and Differences in Regulatory T Cells

  2022cites this paper
• Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy

  2022cites this paper
• Induction of Bystander and Abscopal Effects after Electroporation-Based Treatments

  2022cites this paper
• Regulatory T cells in skeletal muscle repair and regeneration: recent insights

  2022cites this paper
• Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies

  2022influential citation
• CAR-NK cells: a promising cellular immunotherapy in lymphoma

  2022cites this paper
• Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells

  2021cites this paper
• Low-dose interleukin-2-loaded nanoparticle effect on NK and T-reg cell expression in experimentally induced type 1 diabetes mellitus

  2021cites this paper
• Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy

  2021cites this paper
• Innate Lymphoid Cells and Adaptive Immune Cells Cross-Talk: A Secret Talk Revealed in Immune Homeostasis and Different Inflammatory Conditions

  2021cites this paper
• Effect of low dose IL-2 loaded chitosan nanoparticles on natural killer and regulatory T cell expression in experimentally induced autoimmune type 1 diabetes mellitus

  2021cites this paper
• Host genetic control of natural killer cell diversity revealed in the Collaborative Cross

  2021cites this paper
• Harnessing NK Cell Checkpoint-Modulating Immunotherapies

  2020cites this paper
• Innate lymphoid cell and adaptive immune cell cross‐talk: A talk meant not to forget

  2020cites this paper
• ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy

  2020cites this paper
• Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes

  2020cites this paper
• Targeting OCA-B / Pou 2 af 1 blocks type-1 diabetes and reduces 1 infiltration of activated , islet-reactive T cells

  2020cites this paper
• Innate inflammation drives NK cell activation to impair Treg activity.

  2020cites this paper
• Regulatory T Cells and Human Disease.

  2020cites this paper
• Recent Progress in the Synergistic Combination of Nanoparticle‐Mediated Hyperthermia and Immunotherapy for Treatment of Cancer

  2020cites this paper
• Microbiome and Cellular Players in Type 1 Diabetes: From Pathogenesis to Protection

  2020cites this paper
• Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells

  2020cites this paper
• Increased Serum Interleukin-2 Levels Are Associated with Abnormal Peripheral Blood Natural Killer Cell Levels in Patients with Active Rheumatoid Arthritis

  2020cites this paper
• Emerging Concepts on the NKG2D Receptor- NKG2D Ligand Axis in Health and Diseases

  2020cites this paper
• An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice

  2020cites this paper
• An emerging role of regulatory T-cells in cardiovascular repair and regeneration

  2020cites this paper
• Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations

  2020cites this paper
• CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation

  2019cites this paper
• IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation

  2019cites this paper
• Tissue-resident Eomes+ NK cells are the major innate lymphoid cell population in human infant intestine

  2019cites this paper
• Natural Killer Cells in Cancer Immunotherapy

  2019cites this paper
• Functional interactions between innate lymphoid cells and adaptive immunity

  2019cites this paper
• NK Cell-Based Immunotherapy for Hematological Malignancies

  2019cites this paper
• Determining Differential Effects of Interleukin-2 on Innate and Adaptive Immune Cells in Lymphoid Organs and the Gastrointestinal Tract

  2019cites this paper
• PD-L1 blockade enhances anti-tumor efficacy of NK cells

  2018cites this paper
• Attenuation of NK cells facilitates mammary tumor growth in streptozotocin-induced diabetes in mice.

  2018cites this paper
• Treg cells limit IFN-γ production to control macrophage accrual and phenotype during skeletal muscle regeneration

  2018cites this paper
• Tumor immunotherapy: New aspects of natural killer cells.

  2018cites this paper
• The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity

  2018cites this paper
• INTERRELATION OF NERVOUS, IMMUNE, ENDOCRINE SYSTEMS AND NUTRITIONAL FACTORS IN THE REGULATION OF ANIMAL RESISTANCE AND PRODUCTIVITY (review)

  2018cites this paper
• Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers

  2018cites this paper
• Biology and regulation of IL-2: from molecular mechanisms to human therapy

  2018cites this paper
• Thinking differently about ILCs—Not just tissue resident and not just the same as CD4+ T‐cell effectors

  2018cites this paper
• Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma

  2018cites this paper
• Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies

  2018cites this paper
• CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms.

  2018cites this paper
• Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer

  2018cites this paper
• Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis

  2018cites this paper
• Association of peripheral NK cell counts with Helios+IFN‐γ– Tregs in patients with good long‐term renal allograft function

  2017cites this paper
• Imaging the emergence and natural progression of spontaneous autoimmune diabetes

  2017cites this paper
• NK Cell Subsets in Health and Disease: New Developments

  2017influential citation
• CD11a/ICAM‐1 blockade combined with IL‐2 targeting therapy causes a paradoxical acceleration of type 1 diabetes

  2017cites this paper
• Developmental and Functional Control of Natural Killer Cells by Cytokines

  2017cites this paper
• Regulatory T Cells: Central Concepts from Ontogeny to Therapy.

  2017cites this paper
• Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes

  2017cites this paper
• Dynamic Regulation of NK Cell Responsiveness.

  2016cites this paper
• Depletion of IL‐2 receptor β‐positive cells protects from diabetes in non‐obese diabetic mice

  2016cites this paper
• Regulatory T Cell Induction and Retention in the Lungs Drives Suppression of Detrimental Type 2 Th Cells During Pulmonary Cryptococcal Infection

  2016cites this paper
• 4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression

  2016cites this paper
• Natural Killer Cells

  2016cites this paper
• Recognition and Regulation of T Cells by NK Cells

  2016cites this paper
• The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy

  2016cites this paper
• The “Unusual Suspects” in Allograft Rejection: Will T Regulatory Cell Therapy Arrest Them?

  2016cites this paper
• Lymph node – an organ for T‐cell activation and pathogen defense

  2016cites this paper
• Suppression and Regulation of Immune Responses

  2016cites this paper
• Sterol regulatory element binding protein is a crucial regulator of natural killer cell metabolism and function

  2016cites this paper
• NK Cell Proportion and Number Are Influenced by Genetic Loci on Chromosomes 8, 9, and 17

  2016cites this paper
• The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

  2016cites this paper
• Transcriptional Control of NK Cells.

  2016cites this paper
• Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2

  2016cites this paper
• Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes

  2016influential citation
• Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferation

  2016cites this paper
• Immunoregulation in Fungal Diseases

  2016cites this paper
• ILC1s in Tissue Inflammation and Infection

  2016cites this paper
• Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help

  2016cites this paper
• Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study.

  2016cites this paper
• Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias

  2016cites this paper
• Chemoattractant Signals and Adhesion Molecules Promoting Human Regulatory T Cell Recruitment to Porcine Endothelium

  2016cites this paper
• New Molecular and Cellular Mechanisms of Tolerance: Tolerogenic Actions of IL-2.

  2016cites this paper
• The Resolution Phase of NK Cell Proliferation and IFNgamma Production Following Viral Infection Are Highly Regulated Processes

  2016cites this paper
• SA-4-1BBL as a modulator of innate, adaptive, and regulatory immunity : implications for cancer prevention and treatment.

  2016cites this paper